Comparative Pharmacology
Head-to-head clinical analysis: EPICORT versus FLUTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EPICORT versus FLUTEX.
EPICORT vs FLUTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epicort is a corticosteroid that exerts anti-inflammatory and immunosuppressive effects by binding to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of phospholipase A2, thereby reducing prostaglandin and leukotriene synthesis.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
IV: 50 mg every 8 hours over 30 minutes.
50 mg orally once daily
None Documented
None Documented
Terminal half-life is 1.5–2 hours in adults; prolonged to 3–4 hours in severe hepatic impairment
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Renal (70% as unchanged drug and inactive metabolites), biliary/fecal (30%)
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid